MedTrace Logo

Castration-resistant Prostate Cancer and Intra-prostatic Hormonal Status

NCT03014973 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-09-13

No results posted yet for this study

Summary

The main objective of the study is to determine the intra-prostatic concentration of sexual steroids when castration resistance appears in castration-resistant prostate cancer patients compared to patients naif of hormonal treatment

Conditions

Interventions

BIOLOGICAL

intra-prostatic concentration of sexual steroids

PROCEDURE

Trans-rectal biopsy

Sponsors & Collaborators

  • Hopital Foch

    lead OTHER

Principal Investigators

  • Yann NEUZILLET, MD · Hopital Foch

  • Henry Botto, MD · Hopital Foch

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-06-30
Completion
2018-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03014973 on ClinicalTrials.gov